Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,083 | -194,942 | -147,752 | -98,171 | -49,609 |
| Depreciation Amortization | 450 | 2,100 | 1,644 | 1,179 | 608 |
| Accounts receivable | -878 | -9,345 | -5,178 | -689 | 77 |
| Accounts payable and accrued liabilities | -6,944 | 7,777 | 2,844 | -428 | 993 |
| Other Working Capital | -19,620 | -1,536 | -6,104 | -15,155 | -12,504 |
| Other Operating Activity | 17,490 | 49,249 | 36,658 | 25,183 | 10,980 |
| Operating Cash Flow | $-54,585 | $-146,697 | $-117,888 | $-88,081 | $-49,455 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 62,777 | 13,327 | 11,065 | -30,400 | -35,054 |
| PPE Investments | -146 | -778 | -715 | -653 | -360 |
| Investing Cash Flow | $62,631 | $12,549 | $10,350 | $-31,053 | $-35,414 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 522 | 152,638 | 151,748 | 136,158 | 135,320 |
| Other Financing Activity | 0 | -634 | -634 | -634 | -634 |
| Financing Cash Flow | $522 | $152,004 | $151,114 | $135,524 | $134,686 |
| Exchange Rate Effect | -847 | 910 | -230 | 263 | 79 |
| Beginning Cash Position | 83,507 | 64,741 | 64,741 | 64,741 | 64,741 |
| End Cash Position | 91,228 | 83,507 | 108,087 | 81,394 | 114,637 |
| Net Cash Flow | $7,721 | $18,766 | $43,346 | $16,653 | $49,896 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,585 | -146,697 | -117,888 | -88,081 | -49,455 |
| Capital Expenditure | -146 | -778 | -715 | -653 | -360 |
| Free Cash Flow | -54,731 | -147,475 | -118,603 | -88,734 | -49,815 |